Acute Coronary Syndromes and Acute Heart Failure: A Diagnostic Dilemma and High-Risk Combination. A Statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology
Veli‐Pekka Harjola(University of Helsinki), Mehmet Birhan Yılmaz(Istanbul University-Cerrahpaşa), Johann Bauersachs(Medizinische Hochschule Hannover), John R. Teerlink(University of Glasgow), Alain Rudiger(University Hospital of Zurich), Thomas Thum(Medizinische Hochschule Hannover), Gerasimos Filippatos(National and Kapodistrian University of Athens), Loreena Hill(Queen's University Belfast), Rudolf A. de Boer(Erasmus MC), Jyri Lommi(University of Helsinki), W. Frank Peacock(Hennepin Healthcare Research Institute), Effie Polyzogopoulou(National and Kapodistrian University of Athens), Jelena Čelutkienė(Vilnius University), Markku O. Pentikäinen(University of Helsinki), Alessandro Sionís, Marjut Varpula(University of Helsinki), Andrew J.S. Coats(The Heart Research Institute), Héctor Bueno(Centro de Investigación en Red en Enfermedades Cardiovasculares), Marco Metra(Vita-Salute San Raffaele University), Mika Laine(Helsinki University Hospital), Sean P. Collins(Wayne State University), Hans‐Peter Brunner‐La Rocca(Inserm), Josep Masip, Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Johan Lassus(University of Helsinki), Étienne Gayat(Inserm), Petar Seferović, Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Andrea Mortara(Fondazione Lanza), Òscar Miró(Hospital Clínic de Barcelona), John Parissis(National and Kapodistrian University of Athens), Massimo Piepoli(University of Milan), Wilfried Müllens(Ziekenhuis Oost-Limburg), Frank Ruschitzka(Kantonsspital St. Gallen), Christian Mueller(Immutep (Germany)), Jean Marc Weinstein(Soroka Medical Center)
Cited by 89
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k